Literature DB >> 4200654

Cefazolin in the treatment of gonorrhea.

W W Karney, M Turck, K K Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4200654     DOI： 10.1093/infdis/128.supplement_2.s399

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

Review 1.  Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.

Authors:  I Phillips
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 3.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

4.  Prescribing Patterns and Patient Outcomes for Bone and Joint Infections Treated with Cefazolin and Probenecid: A Retrospective Observational Study.

Authors:  Marci E Dearing; Sarah V Burgess; Valerie Murphy; Samuel Campbell; Lynn Johnston; Tasha D Ramsey
Journal:  Can J Hosp Pharm       Date:  2020-06-01

5.  Intravenous (IV) cefazolin with oral probenecid: A novel daily regimen for the management of Methicillin Sensitive Staphylococcus aureus (MSSA) bacteremia in a patient with renal dysfunction.

Authors:  Sunish Shah; Marjorie Golden; Jeffrey E Topal; Dayna McManus
Journal:  IDCases       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.